| ปี พ.ศ. 2560 |
| 1 |
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival |
| 2 |
Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand |
| 3 |
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC |
| ปี พ.ศ. 2559 |
| 4 |
Multiple Neuromas Cause Painful "jumping Stump" in a Transfemoral Amputee |
| 5 |
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer |
| 6 |
Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma |
| ปี พ.ศ. 2557 |
| 7 |
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with reviously treated advanced non-small-cell lung cancer |
| 8 |
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER) |
| 9 |
The cross-cultural adaptation of the DASH questionnaire in Thai (DASH-TH) |
| ปี พ.ศ. 2556 |
| 10 |
Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study |
| ปี พ.ศ. 2555 |
| 11 |
Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective |
| 12 |
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Phase III Trial |
| 13 |
Diabetic Foot Problems in Tertiary Care Diabetic Clinic in Thailand |
| 14 |
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study |
| ปี พ.ศ. 2554 |
| 15 |
Preparation of Pt-based ternary catalyst as cathode material for proton exchange membrane fuel cell by solution route method |
| 16 |
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer |
| 17 |
Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial |
| 18 |
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia |
| 19 |
Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS) |
| 20 |
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer |
| 21 |
Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach |
| 22 |
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS) |
| ปี พ.ศ. 2553 |
| 23 |
Microwave-assisted Pt-Co-Cr/C ternary compound preparation applied as a cathode catalyst for PEMFC |
| 24 |
Lung cancer working group report |
| ปี พ.ศ. 2552 |
| 25 |
A multidisciplinary diabetic foot protocol at chiang mai university hospital: Cost and quality of life |
| 26 |
A multidisciplinary diabetic foot protocol at chiang mai university hospital: Cost and quality of life |
| ปี พ.ศ. 2551 |
| 27 |
Reducing lower extremity amputations due to diabetes: The application of diabetic-foot protocol in Chiang Mai University Hospital |
| 28 |
Reducing lower extremity amputations due to diabetes: The application of diabetic-foot protocol in Chiang Mai University Hospital |
| ปี พ.ศ. 2550 |
| 29 |
The development and application of diabetic foot protocol in Chiang Mai University Hospital with an aim to reduce lower extremity amputation in Thai population: A preliminary communication |
| 30 |
Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer |
| 31 |
The development and application of diabetic foot protocol in Chiang Mai University Hospital with an aim to reduce lower extremity amputation in Thai population: A preliminary communication |
| 32 |
Aerobic capacity of fifth-year medical students at Chiang Mai University |
| 33 |
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer. |
| ปี พ.ศ. 2549 |
| 34 |
Solution route synthesis of dendrite Cu6Sn5 powders, anode material for lithium-ion batteries |
| ปี พ.ศ. 2548 |
| 35 |
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma |
| 36 |
The role of chemotherapy in cholangiocarcinoma |
| 37 |
Lung cancer in Maharaj Nakorn Chiang Mai Hospital: Comparison of the clinical manifestations between the young and old age groups |
| 38 |
Reliability of the Thai-Modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patients |
| ปี พ.ศ. 2547 |
| 39 |
Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients |
| 40 |
Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer |
| ปี พ.ศ. 2546 |
| 41 |
Kaposi's sarcoma in rheumatic diseases |
| ปี พ.ศ. 2545 |
| 42 |
Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer |
| 43 |
Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer |
| ปี พ.ศ. 2544 |
| 44 |
Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer |
| ปี พ.ศ. 2543 |
| 45 |
Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer |
| 46 |
Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer |
| 47 |
Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study |
| ปี พ.ศ. 2542 |
| 48 |
Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy |
| ปี พ.ศ. 2541 |
| 49 |
Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer |
| 50 |
Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer |
| 51 |
Lung cancer and quality of life |
| ปี พ.ศ. 2538 |
| 52 |
Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer |
| ปี พ.ศ. 2537 |
| 53 |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer |
| ปี พ.ศ. 2536 |
| 54 |
Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC) |
| ปี พ.ศ. 2535 |
| 55 |
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital |
| ปี พ.ศ. 2534 |
| 56 |
Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital |
